会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • IgA Nephropathy Testing Method And Test Kit
    • IgA肾病检测方法及检测试剂盒
    • US20110143382A1
    • 2011-06-16
    • US12995507
    • 2009-05-29
    • Takashi ObaraSadaaki MizoguchiOsamu Hotta
    • Takashi ObaraSadaaki MizoguchiOsamu Hotta
    • G01N33/53
    • G01N33/6854G01N2800/347
    • There is provided a renal disease testing method comprising a complex detection step of detecting a complex of an antigen derived from human renal mesangial cells and human IgA in a sample derived from urine collected from a subject. It is preferred that the renal disease testing method of the invention further comprises a determination step of assessing the whether the renal disease is IgA nephropathy based on the ratio of the amount of the complex detected in the complex detection step to the amount of urinary proteins in the sample. The renal disease testing method of the invention has good detection sensitivity and specificity, and can conveniently and safely assess the existence of a renal disease (preferably, IgA nephropathy).
    • 提供了一种肾病检测方法,其包括检测来自受试者收集的尿液的样品中衍生自人肾小球系膜细胞和人IgA的抗原的复合物检测步骤。 优选本发明的肾脏疾病检测方法还包括以下步骤:基于复合物检测步骤检测到的复合物的量与尿蛋白质量的比例来评估肾脏疾病是否为IgA肾病的判定步骤 例子。 本发明的肾病检测方法具有良好的检测灵敏度和特异性,可以方便,安全地评估肾病(优选IgA肾病)的存在。
    • 2. 发明申请
    • IgA Nephropathy Testing Method and Test Kit
    • IgA肾病检测方法及检测试剂盒
    • US20110091915A1
    • 2011-04-21
    • US12995489
    • 2009-05-29
    • Takashi ObaraSadaaki Mizoguchi
    • Takashi ObaraSadaaki Mizoguchi
    • G01N33/53
    • G01N33/6854G01N33/6893G01N2800/347
    • There is provided a renal disease testing method comprising a complex detection step of detecting a complex of human uromodulin and human IgA in a sample derived from urine collected from a subject. It is preferred that the renal disease testing method of the invention further comprises a determination step of assessing the whether the renal disease is IgA nephropathy based on the ratio of the amount of the complex detected in the complex detection step to the amount of urinary proteins in the sample. The renal disease testing method of the invention has good detection sensitivity and specificity, and can conveniently and safely assess the existence of a renal disease (preferably, IgA nephropathy).
    • 提供了一种肾脏疾病测试方法,其包括在从受试者收集的尿中得到的样品中检测人尿调制蛋白和人IgA的复合物的复合物检测步骤。 优选本发明的肾脏疾病检测方法还包括以下步骤:基于复合物检测步骤检测到的复合物的量与尿蛋白质量的比例来评估肾脏疾病是否为IgA肾病的判定步骤 例子。 本发明的肾病检测方法具有良好的检测灵敏度和特异性,可以方便,安全地评估肾病(优选IgA肾病)的存在。
    • 3. 发明授权
    • IgA nephropathy testing method and test kit
    • IgA肾病检测方法及检测试剂盒
    • US08426142B2
    • 2013-04-23
    • US12995489
    • 2009-05-29
    • Takashi ObaraSadaaki Mizoguchi
    • Takashi ObaraSadaaki Mizoguchi
    • G01N33/53
    • G01N33/6854G01N33/6893G01N2800/347
    • There is provided a renal disease testing method comprising a complex detection step of detecting a complex of human uromodulin and human IgA in a sample derived from urine collected from a subject. It is preferred that the renal disease testing method of the invention further comprises a determination step of assessing the whether the renal disease is IgA nephropathy based on the ratio of the amount of the complex detected in the complex detection step to the amount of urinary proteins in the sample. The renal disease testing method of the invention has good detection sensitivity and specificity, and can conveniently and safely assess the existence of a renal disease (preferably, IgA nephropathy).
    • 提供了一种肾脏疾病测试方法,其包括在从受试者收集的尿中得到的样品中检测人尿调制蛋白和人IgA的复合物的复合物检测步骤。 优选本发明的肾脏疾病检测方法还包括以下步骤:基于复合物检测步骤检测到的复合物的量与尿蛋白质量的比例来评估肾脏疾病是否为IgA肾病的判定步骤 例子。 本发明的肾病检测方法具有良好的检测灵敏度和特异性,可以方便,安全地评估肾病(优选IgA肾病)的存在。